LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | A443654 | 0.04 | uM | LJP6 | 72 | hr | 513 | 4000 | 10401 | 0.3846 | 0.3527 |
MCF 10A | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 513 | 7223 | 10401 | 0.6944 | 0.6786 |
MCF 10A | XMD11-85h | 0.04 | uM | LJP6 | 72 | hr | 513 | 9036 | 10401 | 0.8688 | 0.8620 |
MCF 10A | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 513 | 11110 | 10401 | 1.0682 | 1.0717 |
MCF 10A | WH-4-025 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10673 | 10401 | 1.0261 | 1.0275 |
MCF 10A | WZ-4-145 | 0.04 | uM | LJP6 | 72 | hr | 513 | 8831 | 10401 | 0.8491 | 0.8413 |
MCF 10A | XMD16-144 | 0.04 | uM | LJP5 | 72 | hr | 513 | 8960 | 10401 | 0.8615 | 0.8543 |
MCF 10A | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9764 | 10401 | 0.9387 | 0.9356 |
MCF 10A | Buparlisib | 0.04 | uM | LJP5 | 72 | hr | 513 | 10062 | 10401 | 0.9675 | 0.9658 |
MCF 10A | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 513 | 9307 | 10401 | 0.8948 | 0.8893 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 2411 | 10401 | 0.2318 | 0.1920 |
MCF 10A | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 513 | 11579 | 10401 | 1.1132 | 1.1191 |
MCF 10A | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 513 | 4985 | 10401 | 0.4793 | 0.4523 |
MCF 10A | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 513 | 542 | 10401 | 0.0522 | 0.0030 |
MCF 10A | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9979 | 10401 | 0.9594 | 0.9573 |
MCF 10A | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10600 | 10401 | 1.0192 | 1.0202 |
MCF 10A | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 513 | 10852 | 10401 | 1.0433 | 1.0456 |
MCF 10A | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9680 | 10401 | 0.9307 | 0.9271 |
MCF 10A | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 8973 | 10401 | 0.8627 | 0.8556 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 4779 | 10401 | 0.4595 | 0.4314 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 1706 | 10401 | 0.1641 | 0.1207 |
MCF 10A | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9037 | 10401 | 0.8689 | 0.8621 |
MCF 10A | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 513 | 10269 | 10401 | 0.9874 | 0.9867 |
MCF 10A | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 9926 | 10401 | 0.9543 | 0.9520 |
MCF 10A | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 11133 | 10401 | 1.0704 | 1.0741 |